Begin main content

New at CADTH — September 2018

September 17, 2018
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Call for Patient Input: doravirine

September 14, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. doravirine Brand name Generic name Manufacture...

Call for Patient Input: doravirine/lamuvidine/tenofovir disoproxil fumarate

September 14, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. doravirine/lamuvidine/tenofovir disoproxil fum...

2019 CADTH Symposium - Call For Abstracts

September 14, 2018
CADTH is now accepting abstracts for workshops, panels, breakfast sessions, oral presentations, and posters for the 2019 CADTH Symposium to be held in Edmonton, Alberta, April 14 to 16, 2019. The theme is Supporting Health System Transformation. Abstracts must be submitted online at Call for Abstracts. Submission Deadline: Friday, October 26, 2...